Lyell Immunopharma
LYEL
#8241
Rank
NZ$0.31 B
Marketcap
$1.08
Share price
-4.41%
Change (1 day)
-67.82%
Change (1 year)

Lyell Immunopharma (LYEL) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.77 Billion

According to Lyell Immunopharma's latest financial reports the company has NZ$0.77 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lyell Immunopharma - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.86 B-14.34%
2022-12-31NZ$1.00 B12.02%
2021-12-31NZ$0.90 B6.01%
2020-12-31NZ$0.84 B31.13%
2019-12-31NZ$0.64 B